Antonin Holy and Erik De Clercq became co-inventors of a key class of antiviral drugs a.o. Tenofovir to combat the HIV virus
Products resulting from the Holý-De Clercq collaboration and commercialized by Gilead (photo courtesy Gilead Sciences, Inc.)
Medical Faculty in Leuven, Belgium September 13, 2017
EM. PROFESSOR OF BIOMEDICAL SCIENCES
Home
Full profile
Popular Highlights
Archives
More
